Artiva Biotherapeutics expects workforce reduction completion in Q1 2027 and majority of costs in Q4 2026
ARTV•Artiva Biotherapeutics expects to complete its workforce reduction in Q1 2027, with the majority of costs expected in Q4 2026, a filing showed.
1. Workforce reduction timing
Artiva Biotherapeutics expects to complete its workforce reduction in Q1 2027 and incur the majority of costs in Q4 2026, a filing showed.
